National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
 
 
Results: 1 -10 of 20         results per page
View Search Criteria | Help With Results
Title 
Phase sort descending
Protocol IDs 
 
Adjuvant Pazopanib in Stage I NSCLC

   
Phase III, Phase II

   
IFCT-0703
Eudract : 2008-004897-41, NCT00775307

 
 
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

   
Phase III

   
RTOG-0320
NCT00096265

 
 
Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy

   
Phase III

   
SLCSG0501
NCT00300729

 
 
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

   
Phase III

   
ECOG-E1505
E1505, SWOG-E1505, CALGB-E1505, CAN-NCIC-E1505, NCCTG-E1505, NCT00324805

 
 
A Phase III Randomized, Double-Blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)

   
Phase III

   
12006
EudraCT 2006-002688-26, NCT00449033

 
 
A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

   
Phase III

   
A6181087
SUN1087, NCT00457392

 
 
AMG 706/Placebo in Combination With Chemotherapy to Treat Advanced NSCLC

   
Phase III

   
20050201
NCT00460317

 
 
Effect of Low Molecular Weight Heparin :Tinzaparin in Lung Tumours (TILT)

   
Phase III

   
P051084
EUDRACT 2006-005546-36, NCT00475098

 
 
A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

   
Phase III

   
EFC10261
AVE0005, EudraCT 2007-000819-29, NCT00532155

 
 
Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer

   
Phase III

   
2006 BAI02A02[1]-01
NCT00576914

 
      1 2   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov